Co-Crystal Screening

Co-crystals have gained tremendous attention due to their potentials for improving the bioavailability or physicochemical properties of API. Solid State Pharma’s co-crystal screening workflow is on the basis of scientific and rational selection of co-formers.

Our approach utilizes the interaction between functional groups of API and co-formers using a comprehensive database of similar functional groups. When co-crystals are found, Solid State Pharma’s ingenious scientists will construct a ternary phase diagram of the co-crystal with the API in the favored solvent system, as well as characterization of the co-crystal generated.

Ready to collaborate? Let’s work together